Free Trial

BNP Paribas Financial Markets Sells 5,280 Shares of Quaker Chemical Co. (NYSE:KWR)

Quaker Chemical logo with Basic Materials background

BNP Paribas Financial Markets lessened its position in Quaker Chemical Co. (NYSE:KWR - Free Report) by 23.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 17,264 shares of the specialty chemicals company's stock after selling 5,280 shares during the quarter. BNP Paribas Financial Markets owned approximately 0.10% of Quaker Chemical worth $2,430,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of KWR. Bridge City Capital LLC boosted its stake in shares of Quaker Chemical by 0.5% during the 4th quarter. Bridge City Capital LLC now owns 16,107 shares of the specialty chemicals company's stock worth $2,267,000 after buying an additional 85 shares during the last quarter. Covestor Ltd increased its position in shares of Quaker Chemical by 24.8% during the 4th quarter. Covestor Ltd now owns 665 shares of the specialty chemicals company's stock worth $94,000 after purchasing an additional 132 shares during the last quarter. Park Avenue Securities LLC increased its position in shares of Quaker Chemical by 9.2% during the 4th quarter. Park Avenue Securities LLC now owns 1,729 shares of the specialty chemicals company's stock worth $243,000 after purchasing an additional 146 shares during the last quarter. Corient Private Wealth LLC raised its stake in shares of Quaker Chemical by 5.1% during the 4th quarter. Corient Private Wealth LLC now owns 3,095 shares of the specialty chemicals company's stock worth $436,000 after purchasing an additional 149 shares in the last quarter. Finally, KBC Group NV boosted its holdings in shares of Quaker Chemical by 32.8% in the 4th quarter. KBC Group NV now owns 697 shares of the specialty chemicals company's stock valued at $98,000 after buying an additional 172 shares during the last quarter. Institutional investors and hedge funds own 77.46% of the company's stock.

Wall Street Analysts Forecast Growth

KWR has been the topic of a number of recent analyst reports. StockNews.com downgraded shares of Quaker Chemical from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Piper Sandler decreased their price objective on shares of Quaker Chemical from $170.00 to $140.00 and set a "neutral" rating for the company in a research report on Wednesday, April 2nd. Finally, Royal Bank of Canada lowered their price objective on shares of Quaker Chemical from $172.00 to $169.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 26th.

Get Our Latest Research Report on KWR

Quaker Chemical Stock Performance

Shares of NYSE KWR traded up $0.90 during midday trading on Thursday, hitting $105.04. 26,358 shares of the company's stock were exchanged, compared to its average volume of 131,515. The company has a quick ratio of 1.88, a current ratio of 2.54 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $1.86 billion, a PE ratio of 15.40, a price-to-earnings-growth ratio of 1.62 and a beta of 1.42. Quaker Chemical Co. has a 12 month low of $95.91 and a 12 month high of $195.27. The company's 50 day moving average price is $110.68 and its 200 day moving average price is $133.63.

Quaker Chemical (NYSE:KWR - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The specialty chemicals company reported $1.58 EPS for the quarter, topping analysts' consensus estimates of $1.52 by $0.06. Quaker Chemical had a net margin of 6.58% and a return on equity of 10.10%. The firm had revenue of $442.91 million during the quarter, compared to analysts' expectations of $455.23 million. During the same period in the previous year, the business posted $2.09 earnings per share. The company's revenue for the quarter was down 5.7% compared to the same quarter last year. As a group, analysts predict that Quaker Chemical Co. will post 7.75 earnings per share for the current fiscal year.

Quaker Chemical Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Thursday, July 17th will be issued a dividend of $0.485 per share. This represents a $1.94 annualized dividend and a dividend yield of 1.85%. The ex-dividend date is Thursday, July 17th. Quaker Chemical's payout ratio is 36.67%.

Quaker Chemical Company Profile

(Free Report)

Quaker Chemical Corporation, together with its subsidiaries, develops, produces, and markets various formulated specialty chemical products for a range of heavy industrial and manufacturing applications in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals.

See Also

Institutional Ownership by Quarter for Quaker Chemical (NYSE:KWR)

Should You Invest $1,000 in Quaker Chemical Right Now?

Before you consider Quaker Chemical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quaker Chemical wasn't on the list.

While Quaker Chemical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines